J. Zarroug

A pilot investigation of the prevalence of US-detectable forefoot joint pathology and reported foot-related disability in participants with systemic lupus erythematosus

N. Arden, C. Edwards, D. Culliford, 2016, Journal of Foot and Ankle Research.

Dose reduction of biological therapies for inflammatory rheumatic diseases: what do patients think?

J. Adams, C. Holroyd, C. Holmes, 2018, Scandinavian journal of rheumatology.

270 Tapering biological therapies: what do patients think?

C. Edwards, C. Holroyd, C. Holmes, 2018 .

AB1115-HPR Dose Reduction of Biological Therapies in Rheumatoid Arthritis - The Patient's Perspective

J. Adams, C. Holroyd, D. Wallis, 2016 .